University College London innovators and eXmoor strengthen academic-to-clinic gene therapy path
eXmoor Pharma, the UK’s only fully integrated cell and gene therapy CDMO with embedded consultancy expertise, and the Translational Research Office (TRO) at University College London (UCL) have formed a strategic collaboration to accelerate the development of novel cell and gene therapies (CGTs) from academic research…
